Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results - a podcast by American Thoracic Society

from 2022-12-15T11:00

:: ::

Paper discussed in today's episode:
Assessing Pretomanid for Tuberculosis (APT), a Randomized Phase 2 Trial of Pretomanid-containing Regimens for Drug-sensitive TB: 12-Week Results

Further episodes of Out of the Blue: An AJRCCM Podcast

Further podcasts by American Thoracic Society

Website of American Thoracic Society